Evamist.com – What is Evamist® (estradiol transdermal spray)

What is Evamist?

During menopause, your body produces less estrogen, causing many of the symptoms associated with menopause.¹ Evamist uses 17ß-estradiol, an estrogen

chemically synthesized from a plant source.² This does not mean Evamist is safer or more effective than other hormone therapies. Evamist is the only estrogen therapy spray approved by the FDA.

Though there are other products that contain estradiol, only Evamist is a once-daily spray. It delivers low doses of estrogen directly through the skin (transdermally) to your bloodstream.^3,4

Most important, Evamist has been proven to reduce moderate-to-severe hot flashes caused by menopause. It has been shown to reduce both the severity and frequency of hot flashes—all in a low dose of estrogen.³ Doctors agree that hormone therapy should always be used at the lowest effective dose.¹ Evamist makes that easy to do.

Evamist has what women are looking for in an estrogen therapy

Based on a study of women who used Evamist, 82% would recommend Evamist to a friend.^*2 Also, for women who had previously tried an estrogen patch, 3 out of 4 women reported that Evamist was more convenient than their previous patch therapy.^†2

Is Evamist right for you?

Evamist may be right for you. With so many products available for the symptoms of menopause, it can be hard to sift through the array of patches, lotions, gels, and pills. It’s confusing at best, and can be overwhelming for most. Don’t try to decipher it all on your own. Every woman is unique, and it’s important to spend time working with your doctor to create a healthcare plan tailored to your specific needs.

Just because your mother suffered through her menopause symptoms doesn’t mean you have to. Talk to your doctor to see if Evamist may be right for you.

Need to know more about menopause? Check out some of these resources for more information about menopause and available treatments.

On a recent episode of "The Doctors" several health products were hightlighted including Evamist. Click here to view the segment.

*	As reported in an experience study of 247 women using Evamist.²
†	As reported in an experience study of 247 women using Evamist, 53 of whom had previously used estrogen patch therapy.²

» References

Important Safety Information

Evamist^® is approved by the FDA for use after menopause to reduce moderate-to-severe hot flashes.

Estrogens increase the chance of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are using Evamist. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus. Your healthcare provider should check any unusual vaginal bleeding to find out the cause.

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes, or dementia. Using estrogens, with or without progestins, may increase your chance of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogen, with or without progestins, may increase your risk of dementia, based on a study of women age 65 years or older. Evamist should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the past year; currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.

The most common side effects that may occur with Evamist are headache, breast tenderness, the common cold, nipple pain, back pain, nausea, and joint pain.

You and your healthcare provider should talk regularly about whether you still need treatment with Evamist.

Please see full prescribing information for Evamist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.